CABALETTA BIO INC's ticker is CABA and the CUSIP is 12674W109. A total of 97 filers reported holding CABALETTA BIO INC in Q3 2023. The put-call ratio across all filers is 0.78 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,329,855 | +291.6% | 1,532,842 | +232.1% | 0.00% | – |
| Q2 2023 | $5,957,926 | +773.6% | 461,497 | +459.6% | 0.00% | – |
| Q1 2023 | $682,002 | -57.9% | 82,467 | -53.0% | 0.00% | – |
| Q4 2022 | $1,621,840 | +3954.6% | 175,334 | +188.1% | 0.00% | – |
| Q3 2022 | $40,000 | -38.5% | 60,867 | 0.0% | 0.00% | – |
| Q2 2022 | $65,000 | -45.4% | 60,867 | +3.6% | 0.00% | – |
| Q1 2022 | $119,000 | -43.9% | 58,767 | +4.9% | 0.00% | – |
| Q4 2021 | $212,000 | -58.5% | 56,007 | +33.3% | 0.00% | – |
| Q3 2021 | $511,000 | +160.7% | 42,007 | +84.2% | 0.00% | – |
| Q2 2021 | $196,000 | -91.4% | 22,807 | -88.8% | 0.00% | – |
| Q1 2021 | $2,268,000 | -9.0% | 204,316 | +2.3% | 0.00% | – |
| Q4 2020 | $2,491,000 | +41.2% | 199,631 | +22.7% | 0.00% | – |
| Q3 2020 | $1,764,000 | +18.6% | 162,714 | +21.9% | 0.00% | – |
| Q2 2020 | $1,487,000 | +93.4% | 133,492 | +26.7% | 0.00% | – |
| Q1 2020 | $769,000 | +21.5% | 105,399 | +132.6% | 0.00% | – |
| Q4 2019 | $633,000 | – | 45,314 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 2,454,627 | $20,299,765 | 16.92% |
| VR Adviser, LLC | 1,973,251 | $16,318,786 | 3.19% |
| COMMODORE CAPITAL LP | 1,835,000 | $15,175,450 | 2.31% |
| Velan Capital Investment Management LP | 250,000 | $2,067,500 | 1.76% |
| Cormorant Asset Management, LP | 1,821,739 | $15,066 | 0.99% |
| CAXTON CORP | 40,581 | $335,602 | 0.85% |
| TCG Crossover Management, LLC | 486,795 | $4,025,795 | 0.78% |
| Boxer Capital, LLC | 540,000 | $4,466 | 0.22% |
| FRED ALGER MANAGEMENT, LLC | 4,015,310 | $33,206,614 | 0.18% |
| Perceptive Advisors | 724,777 | $5,993,906 | 0.18% |